Laura M Selfors Selected Research

navitoclax

1/2019

Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura M Selfors Research Topics

Disease

21	Neoplasms (Cancer) 01/2023 - 07/2010
10	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2010
4	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 06/2014
2	Carcinogenesis 11/2018 - 06/2013
1	Liver Failure 02/2023
1	Triple Negative Breast Neoplasms 01/2022
1	Starvation 01/2022
1	Carcinoma (Carcinomatosis) 11/2020
1	Ascites 11/2020
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Ovarian Epithelial Carcinoma 03/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017
1	Residual Neoplasm 01/2017
1	Lung Neoplasms (Lung Cancer) 10/2010
1	Lobular Carcinoma 03/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2010
4	Phenobarbital (Luminal)FDA Link 01/2022 - 07/2010
3	Lapatinib (GW572016)FDA Link 01/2021 - 01/2017
2	Estrogen ReceptorsIBA 01/2023 - 06/2013
2	Hormones (Hormone)IBA 01/2023 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2020
2	Transcription Factors (Transcription Factor)IBA 12/2020 - 06/2014
2	Phosphotransferases (Kinase)IBA 01/2020 - 10/2010
1	EnzymesIBA 02/2023
1	Triglycerides (Triacylglycerol)IBA 02/2023
1	ProteomeIBA 01/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	InterferonsIBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Oxidants (Oxidizing Agents)IBA 12/2020
1	LuciferasesIBA 11/2020
1	AmphiregulinIBA 11/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	navitoclaxIBA 01/2019
1	cobimetinibIBA 01/2019
1	Deubiquitinating EnzymesIBA 01/2019
1	AntioxidantsIBA 01/2019
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	TRPA1 Cation ChannelIBA 11/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 03/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Laminin (Merosin)IBA 01/2017
1	Immunoconjugates (Immunoconjugate)IBA 01/2017
1	Glutamine (L-Glutamine)FDA Link 10/2016
1	Transaminases (Aminotransferases)IBA 10/2016
1	A-factor (Streptomyces)IBA 06/2013
1	Profilins (Profilin)IBA 11/2012
1	tyrosine receptor (receptor, tyrosine)IBA 10/2010
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 07/2010
1	Notch ReceptorsIBA 03/2010
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 03/2009

Therapy/Procedure

13	Therapeutics 01/2023 - 02/2012
5	Drug Therapy (Chemotherapy) 01/2019 - 01/2017
1	Transplantation 11/2020
1	Neoadjuvant Therapy 12/2016